Clinical Profiles of Retinal Vasoproliferative Tumors.

IF 0.5 Q4 OPHTHALMOLOGY
Brughanya Subramanian, Purna Nangia, Pukhraj Rishi, Jaydeep Avinash Walinjkar, Dhanashree Ratra, Jaya Prakash Vadivelu, Parthopratim Dutta Majumder, Jyotirmay Biswas, Rajiv Raman
{"title":"Clinical Profiles of Retinal Vasoproliferative Tumors.","authors":"Brughanya Subramanian, Purna Nangia, Pukhraj Rishi, Jaydeep Avinash Walinjkar, Dhanashree Ratra, Jaya Prakash Vadivelu, Parthopratim Dutta Majumder, Jyotirmay Biswas, Rajiv Raman","doi":"10.1177/24741264241296464","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose:</b> To describe the clinical features and treatment outcomes of patients with retinal vasoproliferative tumors. <b>Methods:</b> This retrospective case series comprised patients diagnosed with a retinal vasoproliferative tumor. Electronic medical records were reviewed, and patients' demographic details, clinical presentation, and treatment outcomes were analyzed. <b>Results:</b> Nineteen eyes of 19 patients with vasoproliferative tumors were included. The mean age (±SD) at presentation was 37.0 ± 16.95 years. No eye had bilateral tumors, and 1 eye had multiple tumors. Three eyes (15%) had primary tumors, while 16 (84%) had secondary tumors. Primary tumors mainly affected the inferotemporal quadrant (n = 3). Secondary tumors involved the inferior quadrant (n = 4), inferotemporal quadrant (n = 5), and inferonasal quadrant (n = 5). Secondary tumors were associated with Coats disease (n = 6), intermediate uveitis (n = 3), traumatic chorioretinopathy (n = 2), familial exudative vitreoretinopathy (n = 2), retinal vasculitis (n = 2), and retinal vascular occlusion (n = 1). Retinochoroidal features included intraretinal and subretinal exudates, subretinal fluid, intraretinal hemorrhaging, vitreous hemorrhaging, cystoid macular edema, vitritis, preretinal fibrosis, dilated feeding vessel, epiretinal membranes, and tractional retinal detachment. Treatment modalities included cryotherapy, laser photocoagulation, and local steroids. The mean follow-up was 25.3 months, during which 18 eyes had tumor regression and 1 had a worsening condition. <b>Conclusions:</b> Secondary vasoproliferative tumors were more frequently observed than primary tumors, often presenting as unilateral, unifocal tumors situated posterior to the equator in the inferior fundus. Conventional treatment approaches, such as cryotherapy and laser photocoagulation, were effective at tumor regression and often required multiple sessions.</p>","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264241296464"},"PeriodicalIF":0.5000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11562150/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of VitreoRetinal Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/24741264241296464","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To describe the clinical features and treatment outcomes of patients with retinal vasoproliferative tumors. Methods: This retrospective case series comprised patients diagnosed with a retinal vasoproliferative tumor. Electronic medical records were reviewed, and patients' demographic details, clinical presentation, and treatment outcomes were analyzed. Results: Nineteen eyes of 19 patients with vasoproliferative tumors were included. The mean age (±SD) at presentation was 37.0 ± 16.95 years. No eye had bilateral tumors, and 1 eye had multiple tumors. Three eyes (15%) had primary tumors, while 16 (84%) had secondary tumors. Primary tumors mainly affected the inferotemporal quadrant (n = 3). Secondary tumors involved the inferior quadrant (n = 4), inferotemporal quadrant (n = 5), and inferonasal quadrant (n = 5). Secondary tumors were associated with Coats disease (n = 6), intermediate uveitis (n = 3), traumatic chorioretinopathy (n = 2), familial exudative vitreoretinopathy (n = 2), retinal vasculitis (n = 2), and retinal vascular occlusion (n = 1). Retinochoroidal features included intraretinal and subretinal exudates, subretinal fluid, intraretinal hemorrhaging, vitreous hemorrhaging, cystoid macular edema, vitritis, preretinal fibrosis, dilated feeding vessel, epiretinal membranes, and tractional retinal detachment. Treatment modalities included cryotherapy, laser photocoagulation, and local steroids. The mean follow-up was 25.3 months, during which 18 eyes had tumor regression and 1 had a worsening condition. Conclusions: Secondary vasoproliferative tumors were more frequently observed than primary tumors, often presenting as unilateral, unifocal tumors situated posterior to the equator in the inferior fundus. Conventional treatment approaches, such as cryotherapy and laser photocoagulation, were effective at tumor regression and often required multiple sessions.

视网膜血管增生性肿瘤的临床概况。
目的:描述视网膜血管增生性肿瘤患者的临床特征和治疗效果。方法:该回顾性病例系列包括确诊为视网膜血管增生性肿瘤的患者。回顾电子病历,分析患者的人口统计学细节、临床表现和治疗结果。结果共纳入19名血管增生性肿瘤患者的19只眼睛。发病时的平均年龄(±SD)为 37.0±16.95 岁。没有一只眼为双侧肿瘤,有一只眼为多发性肿瘤。3只眼睛(15%)患有原发性肿瘤,16只眼睛(84%)患有继发性肿瘤。原发性肿瘤主要累及颞下象限(n = 3)。继发性肿瘤累及下象限(4 例)、颞下象限(5 例)和颞下象限(5 例)。继发性肿瘤与Coats病(6例)、中间葡萄膜炎(3例)、外伤性脉络膜视网膜病变(2例)、家族性渗出性玻璃体视网膜病变(2例)、视网膜血管炎(2例)和视网膜血管闭塞(1例)有关。视网膜脉络膜特征包括视网膜内和视网膜下渗出物、视网膜下积液、视网膜内出血、玻璃体出血、囊样黄斑水肿、玻璃体炎、视网膜前纤维化、进血管扩张、视网膜上膜和牵引性视网膜脱离。治疗方法包括冷冻疗法、激光光凝和局部类固醇。平均随访时间为 25.3 个月,其中 18 只眼睛肿瘤消退,1 只眼睛病情恶化。结论是继发性血管增生性肿瘤比原发性肿瘤更常见,通常表现为单侧、单灶肿瘤,位于眼底下部赤道后方。冷冻疗法和激光光凝等常规治疗方法对肿瘤消退有效,但往往需要多次治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.20
自引率
16.70%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信